ArticleJournal of the Endocrine Society2026
Obesity Reduces Endometrial Receptivity by Downregulating the Ob-Rb/STAT-3 Signaling Pathway in Women and Female Mice.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Obesity impairs endometrial receptivity; however, the mechanism remains unclear. Obesity is associated with elevated leptin levels, and leptin receptor (Ob-Rb) has been demonstrated to be expressed in the human endometrium, but the mechanistic pathway of leptin and endometrial dysfunction has not yet been explored. Methods: In a human study, serum leptin levels and expressions of Ob-Rb, signal transducers and activators of transcription (STAT-3), and endometrial receptivity factors [leukemia inhibitory factor (LIF) and vascular endothelial growth factor (VEGF)] were compared in midsecretory phase endometrium among normal-weight, overweight, and obese women. In an animal study of a diet-induced obesity (DIO) mouse model, a leptin resensitization mouse model and Ob-Rb inhibitor mouse model were established. Results: Serum leptin levels were higher in women with overweight/obesity and female DIO mice compared with those with normal weight. The expressions of Ob-Rb, pSTAT-3, and the endometrial receptivity factors of LIF and VEGF were decreased in obese women and DIO mice. Pregnancy rates and the average blastocyst numbers were lower in DIO mice than those in normal-weight mice. After leptin resensitization in DIO mice, the expression of Ob-Rb, pSTAT-3, and endometrial receptivity were increased, whereas these were all decreased in the Ob-Rb inhibitor mouse model compared with normal-weight mice. Conclusion: Obesity-induced Ob-Rb/STAT-3 signaling dysfunction is a central mechanism impairing endometrial receptivity. Leptin resensitization via weight loss partially reverses these effects, suggesting potential therapies for targeting leptin resistance or Ob-Rb/STAT-3 signaling in obesity-related infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.